Google’s much-rumored tablet delayed: report

Google’s much-rumored tablet delayed: report

Google’s much-rumored 7-inch tablet will not be launched until at least July this year, sources close to the Mountain View, California-based firm’s tablet team revealed.

Citing anonymous sources, The Verge reported that Google postpones the launch of its tablet to get more time to find ways to cut costs and drag the tablet’s price down so that it could compete with budget tablets such as the Kindle Fire.

In March, DigiTimes reported that Google had plans to sell a 7-inch tablet with a price tag of around $249. But that price tag is not competitive as the Kindle Fire, which is selling several million units per quarter, costs just $199.

It means Google’s potential tablet will cost around $50 more than the Kindle Fire, which could discourage budget-conscious buyers.

Various reports suggest that the Google tablet will be a Wi-Fi-only tablet that will feature a 7-inch display and a Tegra 3 quad-core chip. But to drag the tablet’s price tag down, Google may ditch the Tegra 3 processor and equip the tablet with a dual-core processor. It may also trim the tablet’s screen quality.


Tagged with

Miscellaneous

Finance Ministry agrees to dole out Rs 1L crore towards fuel subsidy

Finance Ministry agrees to dole out Rs 1L crore towards fuel subsidy

The Finance Ministry has agreed to pay a record Rs 100,000 crore to state-run oil marketing companies towards diesel and cooking fuel subsidy in 2012-13 to help them avoid the impact of the proposed implementation of Export Parity Price (EPP) pricing formula.

The Finance Ministry wants the pricing model to be changed to EPP, but Indian Oil Corporation Ltd (IOCL), Bharat Petroleum Corporation Ltd (BPCL) and Hindustan Petroleum Corporation Ltd (HPCL) are opposing the proposed change as the new model would bring their profitability down to nearly zero.

Ranbaxy episode to hit Indian drug makers’ ability to win new contracts

Ranbaxy episode to hit Indian drug makers’ ability to win new contracts

Ranbaxy might have cross the hurdle of allegations of supplying poor-quality drugs but the episode will hit the Ranbaxy as well as other Indian pharmaceutical firms' businesses in the future, market analysts believe.

Ranbaxy, which is now owned by Diiachi Sankyo of Japan, pleaded guilty to criminal charges of adopting poor manufacturing practices and supplying certain adulterated drugs produced at its two Indian facilities. The company hit a settlement by agreeing to pay $500 millon in civil damages and fines.